Readystate Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Readystate Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$624K	Hold	1,000	–	–	0.02%	590
2026 Q1	$773K	Buy	+1,000	New	+$766K	0.03%	358
2025 Q1	–	Sell	-300	Closed	-$214K	–	720
2024 Q4	$214K	Sell	300 -12,900	-98%	-$10.8M	0.01%	574
2024 Q3	$13.9M	Buy	13,200 +12,800	+3,200%	+$14.2M	0.26%	133
2024 Q2	$420K	Sell	400 -10,400	-96%	-$10.1M	0.01%	566
2024 Q1	$10.4M	Buy	10,800 +10,400	+2,600%	+$9.89M	0.15%	170
2023 Q4	$351K	Buy	400 +100	+33%	+$82.3K	0.01%	501
2023 Q3	$247K	Hold	300	–	–	0.01%	474
2023 Q2	$216K	Sell	300 -100	-25%	-$77.1K	0.02%	269
2023 Q1	$329K	Buy	+400	New	+$302K	0.03%	195

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Readystate Asset Management's REGN Position: Q2 2026 in Review

Readystate Asset Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 530 shares worth $330K. The stake represents 0.01% of the portfolio and ranks #739 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in REGN as recently as Q3 2024.

Readystate Asset Management first reported a position in REGN in Q3 2024 and has held it in 2 quarters since. The position peaked at $5.76M in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Readystate Asset Management held 530 shares of Regeneron Pharmaceuticals worth $330K as of Q2 2026.
Regeneron Pharmaceuticals was a new Readystate Asset Management position in Q2 2026.
Regeneron Pharmaceuticals made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #739 holding.
Readystate Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
Readystate Asset Management's Regeneron Pharmaceuticals position peaked at $5.76M in Q3 2024.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.